HSBC Holdings’s Lunai Bioworks LNAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-164
Closed -$7.38K 3207
2025
Q1
$7.38K Sell
164
-4
-2% -$256 ﹤0.01% 2996
2024
Q4
$11.5K Sell
168
-522
-76% -$34.6K ﹤0.01% 3069
2024
Q3
$26.5K Buy
+690
New +$47.8K ﹤0.01% 2928
2024
Q1
Sell
-188
Closed -$48.8K 3201
2023
Q4
$48.8K Buy
+188
New +$51.5K ﹤0.01% 2650
2021
Q2
Sell
-432
Closed -$122K 3053
2021
Q1
$122K Buy
432
+159
+58% +$46.7K ﹤0.01% 2621
2020
Q4
$67K Buy
+273
New +$69K ﹤0.01% 2974

Other funds holding LNAI

HSBC Holdings's LNAI Position: Q2 2025 in Review

HSBC Holdings sold out of Lunai Bioworks (LNAI) in Q2 2025, closing a stake of 164 shares — an estimated $7.38K sold.

HSBC Holdings first reported a position in LNAI in Q4 2020 and held it in 6 quarters. The position peaked at $122K in Q1 2021. 42 funds tracked by Wall St. Rank hold LNAI as of Q2 2025.

  • HSBC Holdings reported no remaining Lunai Bioworks position as of Q2 2025 after selling out during the quarter.
  • HSBC Holdings sold 164 Lunai Bioworks shares in Q2 2025, an estimated $7.38K.
  • HSBC Holdings first reported a position in Lunai Bioworks in Q4 2020 and held it in 6 quarters.
  • HSBC Holdings's Lunai Bioworks position peaked at $122K in Q1 2021.
  • 42 funds tracked by Wall St. Rank held Lunai Bioworks as of Q2 2025.

Based on HSBC Holdings's 13F filing for Q2 2025, filed 13 Aug 2025.